TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 37.30
-1.00 (-2.61%)
At close: Feb 11, 2026
TCI GENE Market Cap
TCI GENE has a market cap or net worth of 986.9 million as of February 11, 2026. Its market cap has decreased by -32.43% in one year.
Market Cap
986.90M
Enterprise Value
136.03M
Revenue
324.73M
Ranking
n/a
PE Ratio
27.63
Stock Price
37.30
Market Cap Chart
Since January 25, 2022, TCI GENE's market cap has decreased from 2.14B to 986.90M, a decrease of -53.78%. That is a compound annual growth rate of -17.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.01B | 7.89% |
| Dec 31, 2025 | 939.28M | -34.50% |
| Dec 26, 2024 | 1.43B | -35.55% |
| Dec 29, 2023 | 2.23B | -28.42% |
| Dec 30, 2022 | 3.11B | 45.61% |
| Jan 25, 2022 | 2.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 1.30B |
| GeneReach Biotechnology | 1.18B |
| Lukas Biomedical | 1.18B |
| Holy Stone Healthcare | 1.14B |
| Level Biotechnology | 1.07B |
| Taiwan Advance Bio-Pharmaceutical | 990.00M |
| Eusol Biotech | 985.03M |
| NatureWise Biotech & Medicals | 982.35M |